Pfizer's Trading Volume Drops 58% to $626 Million, Ranks 122nd in Market Activity

On June 23, 2025, Pfizer's trading volume reached $626 million, a significant decrease of 58.08% compared to the previous day, ranking 122nd in the day's stock market activity. Pfizer's stock price increased by 0.23%, marking the second consecutive day of gains, with a total increase of 0.61% over the past two days.

Oppenheimer & Co. Inc. increased its stake in Pfizer Inc. by 9.4% during the first quarter, according to its latest filing. This move indicates a growing confidence in the company's prospects among institutional investors.

Gould Capital LLC has expanded its holdings in Pfizer, acquiring an additional 493 shares during the last quarter. This brings the total number of shares owned by the firm to 1,000, valued at $27,000. This acquisition suggests a positive outlook on Pfizer's future performance.

Pfizer's stock is currently considered a deep-value blue-chip investment, offering a dividend yield of over 7%. While the dividend appears secure for the time being, investors are evaluating whether the company's growth potential justifies the current valuation.